Articles

  • Nov 25, 2024 | thefp.com | Jeffrey S. Flier

    This site requires JavaScript to run correctly. Please turn on JavaScript or unblock scripts

  • Nov 25, 2024 | thefp.com | Jeffrey S. Flier

    The Secretary of Health and Human Services oversees an enormous federal agency in charge of Medicare, Medicaid, federally funded biomedical research, public health, and drug approval. In other words, it’s a very important job—and the health of the American people is in that person’s hands. In choosing Robert F. Kennedy Jr. for the role, president-elect Donald Trump has made a profound mistake. That is not because I believe the status quo must be defended.

  • Nov 25, 2024 | urldefense.proofpoint.com | Jeffrey S. Flier

    The Secretary of Health and Human Services oversees an enormous federal agency in charge of Medicare, Medicaid, federally funded biomedical research, public health, and drug approval. In other words, it’s a very important job—and the health of the American people is in that person’s hands. In choosing Robert F. Kennedy Jr. for the role, president-elect Donald Trump has made a profound mistake. That is not because I believe the status quo must be defended.

  • Sep 9, 2024 | statnews.com | Jeffrey S. Flier

    One of the biopharma industry’s marvels of the 2020s has been the enormous medical and financial success of the GLP-1 class of drugs. But the path to commercialization of these therapies was far more complex than most understand, and some of the earliest history has never been presented. Beginning in 1988, I was part of what I believe was the earliest commercial effort to develop GLP-1 as a metabolic therapy.

  • Aug 19, 2024 | thecrimson.com | Jeffrey S. Flier

    A recent policy decision by the American Association of University Professors to drop its categorical opposition to academic boycotts has raised new challenges to academic freedom on campuses worldwide.

Contact details

Socials & Sites

Try JournoFinder For Free

Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.

Start Your 7-Day Free Trial →